Patient Based Studies
Clinical Operations at Veeda Clinical research is headed by Dr. Pranjal Bordoloi. By qualification, he is a M.D. Pharmacology and has joined Veeda with 17 years of illustrious work experience in the industry.
Veeda’s Clinical Operations Department (COD) has a dedicated team of 30 experienced professionals in different functionalities of Project Management, Medical Writing & start-up and Medical Monitoring. This includes 5 project managers (average experience of more than 10 yrs), 3 medical monitors (lead by MD Pharmacology), 3 medical writers (average experience of 7 years), 4 clinical team leaders (average experience of 7 years), 12 CRAs (including 4 regional CRAs) and 3 clinical trial assistants (CTAs). As a team we have completed 29 clinical trials (Phase II, III and patient BA BE studies) in various therapeutic area such as Oncology, Psychiatry, Ophthalmology, Rheumatology, Cardiology, Dermatology, HIV and bone diseases. Clinical Operations team at Veeda has successfully faced total seventeen (17) USFDA inspections at Investigator sites (at which Veeda had conducted PK studies) with no adverse observation.
Veeda Clinical Operations Experience
Veeda Clinical Research has completed 29 patient based clinical studies so far, out of these 23 studies are PK endpoint studies and 6 clinical endpoint studies (4 phase II and 2 phase III). We have enrolled more than 1250 patients in various therapeutic areas and worked with more than 125 sites across India in different therapeutic areas such as Oncology, Psychiatry, Ophthalmology, HIV, Rheumatology, Dermatology and bone diseases.
Patients recruited in different indications
-
Chronic myeloid leukemia (CML)
-
Metastatic Breast Cancer
-
Non-small cell ling cancer (NSCLC)
-
Renal Cell Carcinama (RCC)
-
Colorectal Cancer
-
Ovarian Cancer
-
Small cell lung Cancer (SCLC)
-
Schizophrenia
-
HIV-1
-
Rheumatoid Arthritis
-
Psoriasis
-
Avascular Necrosis
-
Articular Cartilage Defects of the Articulating joints
Investigator’s Database
We have database of more than 600 Investigators sites for which perliminary feasibility evaluation has been done in various therapeutic areas and having capabilities of enrolling patients with following indication with mentioned recruitment rate.
Oncology
Psychiatry
Orthopedics and Rhuematology
Endocrinology
Dermatology
Cardiology
Gastroenterology
Respiratory
Ophthalmology
Urology
ENT
Hematology
MD Physicians
117
37
63
28
75
20
32
38
81
25
35
15
67
WHY PARTNER WITH VEEDA?
- Independent CRO
- 8 years of patient based Clinical trial experience
- Experienced team to handle the criticalities and challenges of the studies
- Scalable team approach
- Proven track record of timely recruitment completion even for are indications like RCC and SCLC
- Database of pre-screened experienced, GCP compliant Investigators with good tested recruiting potential
- Worked with more than 125 Investigators sites in different therapeutic areas
- Excellent regulatory liaison for obtaining DCGI approval/BE - NOC